| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |